| 11858951 |
Boronic acid derivatives |
Oliver Schadt, Christina Esdar |
2024-01-02 |
$178,546,000 |
| 11453647 |
Benzimidazole derivatives as adenosine receptor antagonists |
Eva-Maria TANZER, Kai Schiemann |
2022-09-27 |
$225,705,000 |
| 11274109 |
Boronic acid derivatives |
Oliver Schadt, Christina Esdar |
2022-03-15 |
$190,727,000 |
| 11192899 |
Quinoxaline derivatives as adenosine receptor antagonists |
Eva-Maria TANZER, Kai Schiemann |
2021-12-07 |
$356,600,000 |
| 11186592 |
Thiazolopyridine derivatives as adenosine receptor antagonists |
Eva-Maria TANZER, Kai Schiemann |
2021-11-30 |
$230,654,000 |
| 11178899 |
Producing an aerosol-forming composition |
Jean-Pierre Schaller |
2021-11-23 |
$39,366,000 |
| 10669289 |
Boronic acid derivatives |
Oliver Schadt, Philipp Haselmayer, Mireille Krier |
2020-06-02 |
$232,445,000 |
| 10640520 |
Boronic acid derivatives |
Oliver Schadt, Philipp Haselmayer, Michael Busch |
2020-05-05 |
$140,454,000 |
| 10294246 |
Substituted boronic acids and boronate esters as immunoproteasome inhibitors |
Oliver Schadt, Philipp Haselmayer, Michael Busch |
2019-05-21 |
$423,804,000 |
| 10253049 |
Boronic acid derivatives |
Oliver Schadt, Philipp Haselmayer, Michael Busch |
2019-04-09 |
$108,420,000 |
| 10202418 |
Hydroxy-ethylene derivatives for the treatment of arthrosis |
— |
2019-02-12 |
$137,383,000 |
| 10077288 |
Hydroxystatin derivatives for the treatment of arthrosis |
Christos Tsaklakidis |
2018-09-18 |
$406,016,000 |
| 9884814 |
Acylguanidines for treating osteoarthritis |
Christos Tsaklakidis, Paul Czodrowski |
2018-02-06 |
$115,479,000 |
| 9839665 |
Aminostatin derivatives for the treatment of arthrosis |
Christos Tsaklakidis, Hans Guehring, Birgitta Leuthner |
2017-12-12 |
$85,898,000 |
| 9750784 |
Intraarticular application of pepstatin in the case of arthrosis |
Ralf WODOPIA, Hans Guehring, Sven Lindemann |
2017-09-05 |
$112,151,000 |
| 9663475 |
2 amino-3,4-dihydrcquinazoline derivatives and the use thereof as cathepsin D inhibitors |
Christos Tsaklakidis |
2017-05-30 |
$63,958,000 |
| 9656949 |
Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis |
Sven Lindemann |
2017-05-23 |
$97,197,000 |
| 9624264 |
Hydroxystatin derivatives for the treatment of arthrosis |
Christos Tsaklakidis |
2017-04-18 |
$55,580,000 |
| 9345742 |
Aminostatin derivatives for the treatment of arthrosis |
Christos Tsaklakidis, Hans Guehring, Brigitta Leuthner |
2016-05-24 |
$69,161,000 |
| 9006255 |
Quinazoline derivatives |
— |
2015-04-14 |
$69,458,000 |
| 8895559 |
Quinoxalines derivatives and pharmaceutical compositions and kits |
Ulrich Emde, Hans-Peter Buchstaller, Christina Esdar, Oliver Poeschke |
2014-11-25 |
$61,287,000 |
| 8802866 |
Pyridinylimidazolone derivatives for the inhibition of PI3 kinases |
Ulrich Emde, Hans-Peter Buchstaller, Christina Esdar, Joerg Bomke |
2014-08-12 |
$111,668,000 |
| 8741896 |
Pyrazolopyrimidine derivatives |
Hans-Peter Buchstaller, Ulrich Emde, Christina Esdar, Joerg Bomke |
2014-06-03 |
$91,329,000 |
| 8466170 |
7-azaindole derivatives |
— |
2013-06-18 |
$99,229,000 |
| 8410192 |
Compositions based on silane-terminated polyethers and their use |
Matthias Schaub, Holger Urbas, Gottfried Knispel |
2013-04-02 |
|
